Literature DB >> 15865861

Management of heart failure with pulmonary hypertension.

Mohammed Najeeb Osman1, Mark E Dunlap.   

Abstract

Heart failure (HF) and pulmonary hypertension (PH) coexist frequently and contribute to each other. Because PH often is an insidious disease, the cornerstone of management is the early identification and treatment of its underlying causes, such as left-sided heart disease, left to right shunts, and pulmonary disorders. A practical clinical classification has been proposed by the Third World Symposium on Pulmonary Arterial Hypertension for the purpose of diagnosis and treatment of PH. Thromboembolic pulmonary hypertension should always be considered. Recent studies using vasodilators such as prostacyclins and endothelin antagonists give new hope in the otherwise poor prognosis of idiopathic pulmonary arterial hypertension and its related conditions. Despite optimum medical management, transplantation (lung/heart-lung) remains the choice in severely symptomatic patients.

Entities:  

Mesh:

Year:  2005        PMID: 15865861     DOI: 10.1007/s11886-005-0077-4

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  51 in total

1.  Paul Wood Lecture. The master's legacy: the first Paul Wood Lecture.

Authors:  J Somerville
Journal:  Heart       Date:  1998-12       Impact factor: 5.994

2.  Pulmonary vein stenosis after radiofrequency ablation of atrial fibrillation: functional characterization, evolution, and influence of the ablation strategy.

Authors:  Eduardo B Saad; Antonio Rossillo; Cynthia P Saad; David O Martin; Mandeep Bhargava; Demet Erciyes; Dianna Bash; Michelle Williams-Andrews; Salwa Beheiry; Nassir F Marrouche; James Adams; Ennio Pisanò; Raffaele Fanelli; Domenico Potenza; Antonio Raviele; Aldo Bonso; Sakis Themistoclakis; Joannes Brachmann; Walid I Saliba; Robert A Schweikert; Andrea Natale
Journal:  Circulation       Date:  2003-11-17       Impact factor: 29.690

3.  THE 2D HEART SOUND KEY TO AUSCULTATION OF THE HEART.

Authors:  A LEATHAM
Journal:  Acta Cardiol       Date:  1964       Impact factor: 1.718

4.  Pulmonary arterial hypertension in patients with sleep apnoea syndrome.

Authors:  E Bady; A Achkar; S Pascal; E Orvoen-Frija; J P Laaban
Journal:  Thorax       Date:  2000-11       Impact factor: 9.139

5.  Daytime pulmonary hypertension in patients with obstructive sleep apnea: the effect of continuous positive airway pressure on pulmonary hemodynamics.

Authors:  M Alchanatis; G Tourkohoriti; S Kakouros; E Kosmas; S Podaras; J B Jordanoglou
Journal:  Respiration       Date:  2001       Impact factor: 3.580

6.  Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials.

Authors:  James B Young; Mark E Dunlap; Marc A Pfeffer; Jeffrey L Probstfield; Alain Cohen-Solal; Rainer Dietz; Christopher B Granger; Jaromir Hradec; Jerzy Kuch; Robert S McKelvie; John J V McMurray; Eric L Michelson; Bertil Olofsson; Jan Ostergren; Peter Held; Scott D Solomon; Salim Yusuf; Karl Swedberg
Journal:  Circulation       Date:  2004-10-18       Impact factor: 29.690

7.  Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension.

Authors:  O Sitbon; M Humbert; J L Jagot; O Taravella; M Fartoukh; F Parent; P Herve; G Simonneau
Journal:  Eur Respir J       Date:  1998-08       Impact factor: 16.671

8.  Graded balloon dilation atrial septostomy in severe primary pulmonary hypertension. A therapeutic alternative for patients nonresponsive to vasodilator treatment.

Authors:  J Sandoval; J Gaspar; T Pulido; E Bautista; M L Martínez-Guerra; M Zeballos; A Palomar; A Gómez
Journal:  J Am Coll Cardiol       Date:  1998-08       Impact factor: 24.094

Review 9.  Diagnosis and differential assessment of pulmonary arterial hypertension.

Authors:  Robyn J Barst; Michael McGoon; Adam Torbicki; Olivier Sitbon; Michael J Krowka; Horst Olschewski; Sean Gaine
Journal:  J Am Coll Cardiol       Date:  2004-06-16       Impact factor: 24.094

10.  Impact of catheter ablation on pulmonary vein morphology and mechanical function.

Authors:  David Schwartzman; Hideaki Kanzaki; Raveen Bazaz; John Gorcsan
Journal:  J Cardiovasc Electrophysiol       Date:  2004-02
View more
  1 in total

1.  Investigation of mutual pharmacokinetic interactions between macitentan, a novel endothelin receptor antagonist, and sildenafil in healthy subjects.

Authors:  Patricia N Sidharta; Paul L M van Giersbergen; Michael Wolzt; Jasper Dingemanse
Journal:  Br J Clin Pharmacol       Date:  2014-11       Impact factor: 4.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.